CLRB Latest Quarter's Earnings
| Announce Date | 11/13/2025 |
| EPS Normalized Actual | $-1.41 (Beat by $0.5) |
| EPS GAAP Actual | $-1.41 (Beat by $0.5) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
Upcoming Quarter's Earnings
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.16 |
| EPS GAAP Estimate | $-0.16 |
| Revenue Estimate | $0.012B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | -0.22 | -14.59 | -0.22 | -0.22 | 1 |
| Dec 2028 | 2.57 | 1.25 | 0.59821 | 4.54179 | 1 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -1.41 | -1.12 | 0B | NAN% | -3M |
| FQ2 2025 (Jun 2025) | -3.39 | -3.19 | 0B | NAN% | -3M |
| FQ1 2025 (Mar 2025) | -0.14 | 0.16 | 0B | NAN% | 0M |
| FQ4 2024 (Dec 2024) | 0.13 | 0.44 | 0B | NAN% | 0M |
| FQ3 2024 (Sep 2024) | -0.41 | -1.95141 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | -0.0257 | -0.0257 | 0B | NAN% | 0M |
| FQ1 2024 (Mar 2024) | -0.74 | -0.74 | 0B | NAN% | 0M |
| FQ4 2023 (Dec 2023) | -0.4 | -0.4 | 0B | NAN% | 0M |
Quarterly Estimates Summary
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.16
Consensus Revenue Estimates
0.012B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Oct 2026) | 0 | -- | 0 | 0 | 0 |
| FQ3 2026 (Jul 2026) | 0 | INF | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | -0.08 | -4137.5 | -0.08 | -0.08 | 1 |
| FQ1 2026 (Mar 2026) | -0.16 | 12.5 | -0.16 | -0.16 | 1 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Oct 2026) | 0.02B | -- | 0.02B | 0.02B | 0 |
| FQ3 2026 (Jul 2026) | 0.02B | -- | 0.02B | 0.02B | 0 |
| FQ2 2026 (Jun 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ1 2026 (Mar 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
0
Revenue # of Misses
2
Revenue # of in-lines
6
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.29 | -1.41 | -1.12 | 79.43% |
| FQ2 2025 (Jun 2025) | -0.2 | -3.39 | -3.19 | 94.1% |
| FQ1 2025 (Mar 2025) | -0.3 | -0.14 | 0.16 | -114.29% |
| FQ4 2024 (Dec 2024) | -0.31 | 0.13 | 0.44 | 338.46% |
| FQ3 2024 (Sep 2024) | 1.54141 | -0.41 | -1.95141 | 475.95% |
| FQ2 2024 (Jun 2024) | -0.0257 | -0.0257 | 100% | |
| FQ1 2024 (Mar 2024) | -0.74 | -0.74 | 100% | |
| FQ4 2023 (Dec 2023) | -0.4 | -0.4 | 100% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0B | $-3M | -INF% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $-3M | -INF% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
CLRB Ratings Summary
CLRB Quant Ranking
